Negative Results of Nucleic Acid Amplification Tests for SARS-CoV-2 in Clinical Practice May Vary among Six Molecular Assays in Patients with COVID-19

Several commercial nucleic acid amplification tests (NAATs) for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have been developed. We used 6 kits available in Japan in 13 NAAT-positive specimens with crossing point values >36 and 7 NAAT-negative specimens from patients with coronav...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Japanese Journal of Infectious Diseases 2022/05/31, Vol.75(3), pp.309-313
Hauptverfasser:	Motohashi, Ayano, Yamamoto, Kei, Mezaki, Kazuhisa, Moriya, Ataru, Kurokawa, Masami, Oki, Hitoshi, Ando, Honami, Isaka, Erina, Usami, Ayaka, Ide, Satoshi, Nakamura, Keiji, Nakamoto, Takato, Nomoto, Hidetoshi, Ohmagari, Norio
Format:	Artikel
Sprache:	eng
Schlagworte:	Amplification Coronaviruses COVID-19 COVID-19 - diagnosis Humans Infectivity molecular diagnostics Negative Results Nucleic Acid Amplification Techniques - methods Nucleic acids Patients quantitative reverse-transcription polymerase chain reaction SARS-CoV-2 SARS-CoV-2 - genetics Sensitivity and Specificity Severe acute respiratory syndrome Severe acute respiratory syndrome coronavirus 2 Viral diseases
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!